First Round of Late-Breaking Clinical Trial Results Announced at VIVA22

/PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and...

Related Keywords

Japan ,United States ,Kenneth Rosenfield ,Wynn Las Vegas ,Michael Lichtenberg ,Mehdi Shishehbor ,Ehrinj Armstrong ,Sean Lyden ,Transcend ,Peripheral Academic Research Consortium ,Surmodics Inc ,Journal Of The American College Cardiology ,Medtronic ,Late Breaking Clinical Trials ,Wynn Las ,Vascular Interventional Advances ,Propensity Adjusted Comparison ,Drug Coated Balloons Versus Bare Metal Stents ,Femoropopliteal Lesions ,Three Year Results ,American College ,Next Generation Paclitaxel Drug Coated Balloon ,Femoropopliteal Artery ,Walking Impairment Questionnaire ,Peripheral Artery Questionnaire ,Femoropopliteal Disease ,One Year Outcomes ,Month Outcomes ,Longer Lesions ,Subgroup Analysis ,Veryan Medical ,Peripheral Artery Calcification ,Results From ,Shockwave Medical ,